The SLC17A3 gene gives kidney cells instructions for moving uric acid and some other waste products into urine. This gene helps your body keep uric acid levels in a healthier range. If it works less well, uric acid may build up in the blood, which can raise the chance of gout and sometimes kidney stones. Common variants in this gene usually affect risk rather than cause disease on their own.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or managing activities in the body. Some genes carry the information needed to produce proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
SLC17A3Gene function
What if the gene works
The SLC17A3 gene helps kidney cells move uric acid and certain other waste substances into urine. This supports the body’s usual process for clearing them from the blood.
Risk
What if the gene does not work
Milder to more severe variants in the SLC17A3 gene can reduce how kidney tubule cells move urate and other small charged waste molecules into urine. This lowers transporter activity at the cell surface and changes normal urate handling.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the SLC17A3 gene is currently established in clinical guidelines. The SLC17A3 gene is being studied as a biomarker that may help explain differences in uric acid lowering treatment response, but this has not changed routine drug selection.
Gene function
What if the gene works
Your kidneys constantly sort the blood and send waste into urine. In that daily process, the SLC17A3 gene helps kidney cells move certain charged waste substances to the urine side. One of these is uric acid, a normal breakdown product from the body.
In kidney tubule cells, the SLC17A3 gene helps move uric acid into urine. This supports normal uric acid balance and helps explain how the kidneys remove uric acid each day.
This gene also helps transport other small charged waste substances (organic anions) out of kidney cells. These are normal body chemicals that need to be cleared into urine.
The protein made from the SLC17A3 gene sits on the urine side of certain kidney cells. From there, it moves selected waste substances from the cell into the forming urine.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental factors. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SLC17A3 gene can alter how well its transporter is made, folded, moved to the cell surface, or able to export urate and some other waste molecules. In discussions of how SLC17A3 variants affect urate transport, the main issue is how much the change lowers transporter activity. Some variants have mild effects, while more disruptive variants can sharply reduce transport or nearly eliminate it. This creates a spectrum of functional impact at the cellular level.
How variants are linked to conditions
Variants in the SLC17A3 gene are most consistently linked to blood uric acid levels and gout. In studies of SLC17A3 gene variants and gout, some changes are associated with a higher chance of gout or high uric acid, while others are associated with lower uric acid levels. These findings describe shifts in risk, not a diagnosis, because gout also depends on diet, kidney health, medicines, and other genes.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are frequent in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental influences also play a role. In some situations, though, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC17A3, some gene changes are linked to higher uric acid levels, which can raise the chance of gout or kidney stones. That risk can also be shaped by other genes and everyday factors such as body weight, alcohol use, dehydration, and a diet high in purines, including large amounts of red meat and some seafood.
Inheritance of SLC17A3 variants
Understanding how SLC17A3 gene variants are inherited is still evolving. There is not yet a broadly confirmed Mendelian inheritance pattern for the SLC17A3 gene tied to a specific, well-established genetic condition. Most findings about this gene relate to shifts in uric acid levels or gout risk, which reflect inherited tendencies rather than a single clear-cut dominant or recessive pattern. The SLC17A3 gene is located on chromosome 6, which is an autosome, so you inherit one copy from each parent.
What does my SLC17A3 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific inherited condition for the SLC17A3 gene, although research on this gene is still developing. If you have a specific SLC17A3 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can help explain it in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
SLC17A3 genetic testing uses a blood sample, saliva, or a cheek swab to read the DNA code of the SLC17A3 gene and look for variants. Results may show no relevant variant, a known disease causing variant, or a variant of uncertain significance, which means the change is not yet fully understood.
When should I consider getting a genetic test?
There is not yet a broadly established, SLC17A3-specific clinical reason for genetic testing in routine care. Decisions about testing are usually based on your personal or family history of high uric acid, gout, kidney stones, or kidney problems and discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, but how much they reveal varies based on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results can also help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same medication works well for one person, works less well for another, or causes more side effects in someone else. These differences are common and are one of several factors, along with age, kidney and liver function, and other medicines, that can shape treatment response.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies gene-drug patterns to help explain why the same treatment can work differently in different people. For many drugs, genes influence either how strongly a medicine works or how the body handles it. This information can support treatment decisions that are both better informed and more individualized. More details on this topic are available in the LearnHub.
Drugs influenced by the SLC17A3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing. If you have concerns about side effects, a medicine not working as expected, or health issues that may affect treatment, discuss them with your doctor.
History
SLC17A3 came into medical genetics through research on uric acid levels and gout, especially as genome-wide studies expanded in the 2000s. Scientists first recognized it as part of a broader family of transport genes, then linked common variants near the SLC17A3 gene to differences in blood uric acid in large population studies. From these first observations, research expanded steadily. As these findings were repeated in different groups, the gene became part of a clearer picture of why some people are more likely to develop high uric acid or gout. Its history is mostly tied to this era of modern genetic studies rather than to a single dramatic discovery or public event.